药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trilostane
Mepyramine
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Mepyramine.
Trilostane
Pasireotide
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Pasireotide.
Trilostane
Cariporide
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Cariporide.
Trilostane
Amisulpride
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Amisulpride.
Trilostane
Vernakalant
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Vernakalant.
Trilostane
Tandutinib
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Tandutinib.
Trilostane
Methsuximide
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Methsuximide.
Trilostane
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Indacaterol.
Trilostane
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Indacaterol.
Trilostane
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Indacaterol.
Trilostane
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Indacaterol.
Trilostane
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Indacaterol.
Trilostane
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Indacaterol.
Trilostane
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Indacaterol.
Trilostane
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Indacaterol.
Trilostane
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Indacaterol.
Trilostane
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Indacaterol.
Trilostane
Landiolol
The therapeutic efficacy of Landiolol can be decreased when used in combination with Indacaterol.
Trilostane
Epanolol
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Epanolol.
Trilostane
Esatenolol
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Esatenolol.